We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses changes in the dose and field of radiation treatment for head and neck cancers. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Thank you to our sponsor #Merck!
Author: Editor
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses using induction to guide radiation. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Thanks to our sponsor #Merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses using surgery as a tool to determine radiation usage. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Thanks to our sponsor #Merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses what factors determine if a patient qualifies for de-escalation. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Thank you to our sponsor #Merck!
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this first video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma discusses her diagnosis and her next steps for dealing with the treatment of this rare cancer. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this next video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma discusses her diagnosis and her next steps for dealing with the treatment of this rare cancer. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/gall-bladder-and-bile-duct-cancer-cholangiocarcinoma
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma discusses lifting the barriers to entry and acceptance into a clinical trial. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly To join the conversation, https://cancergrace.org/forums/gall-bladder-and-bile-duct-cancer-cholangiocarcinoma For more, please visit http://cancerGRACE.org/.
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this final video, Melinda Bachini, a 12-year survivor of cholangiocarcinoma shares the milestones she has reached, and personal information about the important time that she has been given, because of her ability to participate in a clinical trial. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly To join the conversation, https://cancergrace.org/forums/gall-bladder-and-bile-duct-cancer-cholangiocarcinoma For more,…
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video series, we talk with Jared Bigman. In the span of almost nine years, Jared has had more than six cancer recurrences and participated in four clinical trials. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video series, we talk with Jared Bigman. In the span of almost nine years, Jared has had more than six cancer recurrences and participated in four clinical trials. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video series, we talk with Jared Bigman. In the span of almost nine years, Jared has had more than six cancer recurrences and participated in four clinical trials. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey. In this video series, we talk with Jared Bigman. In the span of almost nine years, Jared has had more than six cancer recurrences and participated in four clinical trials. Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Associate Professor of Hematology and Medical Oncology, Associate Professor of Oncological Sciences and Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai Hospital joins us to discuss emerging immunotherapy treatments for B-Cell Non-Hodgkin’s Lymphoma: CAR-T Cells. For this video update, Dr. Joshua Brody gives an in-depth explanation of CAR-T cells and their role in treating Non-Hodgkin’s Lymphoma. Thank you to our sponsors! #karyopharm #pharmacyclics For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/blood-cancer.
For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Associate Professor of Hematology and Medical Oncology, Associate Professor of Oncological Sciences and Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai Hospital joins us to discuss emerging immunotherapy treatments for B-Cell Non-Hodgkin’s Lymphoma: Bispecific Antibodies. For this video update, Dr. Joshua Brody discusses the use of bispecific antibodies in the treatment of Non-Hodgkin’s Lymphoma. Thank you to our sponsors! #karyopharm #pharmacyclics For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/blood-cancer.
For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC San Diego with specialties in Leukemia & Lymphoma, Blood & Marrow Transplant, and Medical Oncology talks about treatment options for Relapsed Diffuse Large B-Cell Lymphoma. For this video update, Dr. Aaron Goodman discusses treatment options for patients who relapse after R-CHOP first-line treatment. Thank you to our sponsors! For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/blood-cancer.
For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC San Diego with specialties in Leukemia & Lymphoma, Blood & Marrow Transplant, and Medical Oncology, shares information about CAR T-cell therapy. For this video update, Dr. Aaron Goodman explains the process of CAR-T Cell Therapy. Thank you to our sponsors! For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/blood-cancer.
For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC San Diego with specialties in Leukemia & Lymphoma, Blood & Marrow Transplant, and Medical Oncology, talks about CAR T-cell therapy. For this video update, Dr. Aaron Goodman discusses two main side effects of CAR-T Cell Therapy: Cytokine Release Syndrome and ICANS. Thank you to our sponsors! For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/blood-cancer.
For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC San Diego with specialties in Leukemia & Lymphoma, Blood & Marrow Transplant, and Medical Oncology, shares information about CAR T-cell therapy. For this video, Dr. Aaron Goodman gives a brief explanation of three current types of CAR-T cell therapy. Thank you to our sponsors! For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forums/blood-cancer.
For the GRACE Blood Cancer Video Library, joining us is Dr. Marco Ruiz, M.D., MPH, FACP, FIDSA, Chief of HIV Oncology and HIV Stem Cell Transplantation at Miami Cancer Institute, specializing in the treatment of hematologic cancers including leukemia, lymphoma, myelodysplastic syndrome, and myelofibrosis, as well as cancer combined with human immunodeficiency virus (HIV). Dr. Ruiz has unique expertise in bone marrow transplantation, geriatric oncology, and palliative medicine. For this video, Dr. Marco Ruiz discusses the importance of cancer care in HIV-Infected patients, and strategies to improve their care overall. Thank you to our sponsors! For more, please visit http://cancerGRACE.org/.…
For the GRACE Blood Cancer Video Library, joining us is Dr. Marco Ruiz, M.D., MPH, FACP, FIDSA, Chief of HIV Oncology and HIV Stem Cell Transplantation at Miami Cancer Institute, specializing in the treatment of hematologic cancers including leukemia, lymphoma, myelodysplastic syndrome, and myelofibrosis, as well as cancer combined with human immunodeficiency virus (HIV). Dr. Ruiz has unique expertise in bone marrow transplantation, geriatric oncology, and palliative medicine. For this video, Dr. Marco Ruiz discusses how to best handle blood cancers in geriatric patients, and specific issues pertaining to their age group. Thank you to our sponsors! For more, please…
For the GRACE Blood Cancer Video Library, joining us is Dr. Marco Ruiz, M.D., MPH, FACP, FIDSA, Chief of HIV Oncology and HIV Stem Cell Transplantation at Miami Cancer Institute, specializing in the treatment of hematologic cancers including leukemia, lymphoma, myelodysplastic syndrome, and myelofibrosis, as well as cancer combined with human immunodeficiency virus (HIV). Dr. Ruiz has unique expertise in bone marrow transplantation, geriatric oncology, and palliative medicine. For this video, Dr. Marco Ruiz discusses the growing gaps in cancer treatment of ethnic minorities, and how to address those gaps. Thank you to our sponsors! For more, please visit http://cancerGRACE.org/.…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown explains what a biomarker is, and why they are important in cancer. A huge thank you…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown discusses PD-L1 scores in treatment of bladder cancer. A huge thank you to our sponsor! #pfizer…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown examines tumor mutation burden, and explains the role of neoantigens. A huge thank you to our…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown looks at types of immune cells, including lymphocytes and macrophages. A huge thank you to our…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown discusses emerging research on the effect of microbiomes and genomics on immunotherapy in bladder cancer. A…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown explains circulating tumor DNA, and its role in determining immunotherapy effectiveness. A huge thank you to…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Jason Brown looks at how artificial intelligence can be utilized in combining multiple biomarkers. A huge thank you…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Shilpa Gupta discusses the current treatment paradigm for patients with bladder cancer. A huge thank you to our…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Shilpa Gupta discusses the definition of platinum ineligibility and its criteria. A huge thank you to our sponsor!…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine, and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Shilpa Gupta looks at the Keynote 361 study, which examined Pembrolizumab versus Carbo-Gem. A huge thank you to…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine, and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Shilpa Gupta gives a brief overview of the history of first-line therapy in patients unable to take Cisplatin.…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine, and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center. In this video, Dr. Petros Grivas discusses the Ambassador Trial, which studied Pembrolizumab in muscle-invasive and locally advanced disease. A huge thank…
Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video series on making high-quality decisions when it comes to cancer care. For this series, Dr. Kwon discusses the decision-making process with Fred, who has been diagnosed with prostate cancer. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this first video, Dr. Kwon and Fred discuss making high-quality decisions and looking at treatment options. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. #exelixis #lilly #genentech
Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video series on making high-quality decisions when it comes to cancer care. For this series, Dr. Kwon discusses the decision-making process with Fred, who has been diagnosed with prostate cancer. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss prostate cancer and knowing his options. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. #exelixis #lilly #genentech
Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video series on making high-quality decisions when it comes to cancer care. For this series, Dr. Kwon discusses the decision-making process with Fred, who has been diagnosed with prostate cancer. Fred candidly discusses his decision-making process and what he has learned through his cancer journey. In this video, Dr. Kwon and Fred discuss when to start treatment. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. #exelixis #lilly #genentech
We are excited to bring new and updated information to share through our Lung Cancer Video Library. For this video series, we are pleased to work with Dr. Christina Baik, Oncologist at Seattle Cancer Care Alliance, Associate Professor of Medicine at the University of Washington, and Associate Professor, Clinical Research Division of the Fred Hutchinson Cancer Care Research Center; Dr. Melina Marmarelis, Hematology and Oncology professional and Assistant Professor of Medicine at the Hospital of the University of Pennsylvania; Dr. Sandip Patel, Medical Oncologist and Associate Professor of Medicine at UC San Diego Health; Dr. Tejas Patil, Medical Oncologist and…
EHA 2022 Conference Coverage EHA 2022 (European Hematology Association) Conference Coverage – Synopsis Below EHA 2022 (European Hematology Association) Phase 3, Placebo-Controlled, Randomized Clinical Trial Of PI3K Delta Inhibitor Leniolisib In Patients With Activated PI3K Delta Syndrome. Click Here to watch Just the PI3K Delta Inhibitor Phase 3 Trial Video from EHA 2022 Is Hematopoietic Stem Cell the only APDS Option? V. Koneti Rao, MD, FRCPA, Senior Research Physician, Primary Immune Deficiency Clinic (ALPS Clinic). He provides direct clinical care to patients at the NIH Clinical Center. Presented at EHA 2022 the ADPS or Activated PI3K Delta Syndrome is a…
This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer. Faculty provide practical guidance to apply available and emerging data in real-world decision-making that clinicians are faced with on a daily basis including: interpreting results to inform treatment decisions, biomarker testing, patient selection, and combination therapy. Video modules are also available as downloadable audio podcasts and transcripts. Claim credit: https://www.achlcme.org/prostate-cancer-onctube
This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer. Faculty provide practical guidance to apply available and emerging data in real-world decision-making that clinicians are faced with on a daily basis including: interpreting results to inform treatment decisions, biomarker testing, patient selection, and combination therapy. Video modules are also available as downloadable audio podcasts and transcripts. Claim credit: https://www.achlcme.org/prostate-cancer-onctube
This educational activity features a panel consisting of an oncologist as well as leading experts (a urologist and a researcher) in prostate cancer care considerations in gay and bisexual men (GBM). This panel discusses quality of life considerations and disparities among GBM with prostate cancer. The panel’s aim is to provide clinicians with real-world strategies to facilitate optimal communication and shared decision-making with these patients. This initiative also provides the latest epidemiological and clinical data, controversies, and evolving treatment practices to improve patient-reported outcomes. Additionally, a gay patient shares his prostate cancer story and perspectives to better illustrate and help…
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy. Claim credit: https://www.achlcme.org/aml-maintenance-therapy-onctube
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy.Claim credit: https://www.achlcme.org/aml-maintenance-therapy-onctube
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy. Claim credit: https://www.achlcme.org/aml-maintenance-therapy-onctube
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy. Claim credit: https://www.achlcme.org/aml-maintenance-therapy-onctube
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy.Claim credit: https://www.achlcme.org/aml-maintenance-therapy-onctube
This quick, comprehensive video reviews the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and management of adverse events in patients receiving this therapy. Claim credit: https://www.achlcme.org/iron-replacement-therapy-onctube
In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience to establish optimal recognition, diagnostic, and treatment practices, and discuss opportunities for shared decision making with patients. Learners are questioned about how they would proceed at different clinical decision points, and faculty commentaries offer recommendations and evidence for next steps. This activity outlines ways to identify and diagnose patients with nonspecific symptoms, differentiate between risk levels, and choose appropriate therapeutic options. Claim credit: https://www.achlcme.org/mds-advances-onctube
In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience to establish optimal recognition, diagnostic, and treatment practices, and discuss opportunities for shared decision-making with patients. Learners are questioned about how they would proceed at different clinical decision points, and faculty commentaries offer recommendations and evidence for next steps. This activity outlines ways to identify and diagnose patients with nonspecific symptoms, differentiate between risk levels, and choose appropriate therapeutic options. Â Claim credit: https://www.achlcme.org/mds-advances-onctube
Are you involved in treating patients with triple negative breast cancer (TNBC)? The emergence of TROP2-directed antibody drug conjugate (ADC) technology has paved the way for exciting new targeted treatment approaches for patients with TNBC. This expert-led recording from a series of national visiting lecture series updates clinicians on how recently approved and investigational ADCs overcome current challenges in TNBC treatment. This activity also reviews patient cases that incorporate the latest clinical evidence and recommendations. The activity includes excerpts from the live question and answer session as well as downloadable resources to improve care for your patients with TNBC. Claim…